Display Settings:

Format

Send to:

Choose Destination
    J Invest Dermatol. 1990 Dec;95(6 Suppl):166S-169S.

    Interferon in the treatment of AIDS-associated Kaposi's sarcoma: the American experience.

    Source

    Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

    Abstract

    This report is intended to summarize the use of Interferon in the treatment of Kaposi's sarcoma (KS) associated with AIDS. The review is basically focused on the trials in the United States, which resulted in approval by the Food & Drug Administration (FDA) of the use of recombinant interferon alpha for the treatment of Kaposi's sarcoma.

    PMID:
    1701804
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk